Back to search
Smokeless Tobacco
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Smokeless Tobacco trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Smokeless Tobacco trials you may qualify forThis study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.
To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (S…
DIP : To conduct a pragmatic, non-blinded randomized controlled trial (pRCT) of immediate in-patient postpartum OGTT prior to delivery discharge (intervention)…
The transient diplopias (TD) is defined by a short diplopia. Their etiology may be ophthalmological, neurological non-ischemic or of ischemic origin. The diffi…
Mobile health (mHealth) will be used for early detection of oral cancer and pre-cancer lesions, and to improve awareness of oral cancer among the population and…
This is a wait-list control trial to test for efficacy of the All Nations Snuff Out Smokeless (ANSOS) recreational tobacco cessation program in multi-tribal Ame…
This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising cla…
Cigarette smoking prevalence has decreased to \~12% in 2022; however, over 40 million U.S. adults were current cigarette smokers in the same year. Rural-urban d…